Zacytuj

1. Fournier JA, Cabezon S, Cayuela A, Ballesteros SM, Cortacero JA, Diaz De La Llera LS. Long-term prognosis of patients having acute myocardial infarction when ≤40 years of age. Am J Cardiol. 2004;94:989-992. doi: 10.1016/j.amjcard.2004.06.051.10.1016/j.amjcard.2004.06.05115476609Open DOISearch in Google Scholar

2. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315-2381. doi: 10.1093/eurheartj/ehw106.10.1093/eurheartj/ehw106498603027222591Open DOISearch in Google Scholar

3. Shah N, Kelly AM, Cox N, Wong C, Soon K. Myocardial infarction in the "young": risk factors, presentation, management and prognosis. Heart Lung Circ. 2016;25:955-960. doi: 10.1016/j.hlc.2016.04.015.10.1016/j.hlc.2016.04.01527265644Open DOISearch in Google Scholar

4. Gale CP, Allan V, Cattle BA, et al. Trends in hospital treatments, including revascularization, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). Heart. 2014;100:582-589. doi: 10.1136/heartjnl-2013-304517.10.1136/heartjnl-2013-30451724436220Open DOISearch in Google Scholar

5. Yunyun W, Tong L, Yingwu L, et al. Analysis of risk factors of ST-segment elevation myocardial infarction in young patients. BMC Cardiovasc Disord. 2014;14:179. doi: 10.1186/1471-2261-14-179.10.1186/1471-2261-14-179427148025487289Open DOISearch in Google Scholar

6. Hoit B, Gilpin E, Henning H, et al. Myocardial infarction in young patients: an analysis by age subsets. Circulation. 1986;4:712-721.10.1161/01.CIR.74.4.7123757185Search in Google Scholar

7. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39:119-177. doi: 10.1093/eurheartj/ehx393.10.1093/eurheartj/ehx39328886621Open DOISearch in Google Scholar

8. Akram MV, Zaidi F, Bansal S, Kishore K. A study of risk factors in young patients of myocardial infaction. Int J Res Med Sci. 2015;3:2677-2681. doi: http://dx.doi.org/10.18203/2320-6012.ijrms20150813.10.18203/2320-6012.ijrms20150813Search in Google Scholar

9. Kannel WB, Abbott RD. Incidence and prognosis of unrecognised myocardial infarction. An update on the Framingham study. New Eng J Med. 1984;311:1144-1147. doi: 10.1056/NEJM198411013111802.10.1056/NEJM1984110131118026482932Open DOISearch in Google Scholar

10. Ge J, Li J, Yu H, An Y. Acute myocardial infarction in young adults: risck factors, clinical features and management strategies. Cardiology Plus. 2017;2:23-27. doi: 10.4103/2470-7511.248220.Search in Google Scholar

11. Goel A, Goel D, Yadav Y. A clinical study of risk factors associated with young patients of myocardial infarction. J Evolution Med Dent Sci. 2016;5:6588-6591. doi: 10.14260/jemds/2016/1489.10.14260/jemds/2016/1489Search in Google Scholar

12. Egiziano G, Akhtari S, Pilote L, Daskalopoulou SS. Sex differences in young patients with acute myocardial infarction. Diabet Med. 2013;30:e108–114. doi: 10.1111/dme.12084.10.1111/dme.12084Open DOISearch in Google Scholar

13. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952. doi: 10.1016/S0140-6736(04)17018-9.10.1016/S0140-6736(04)17018-9Open DOISearch in Google Scholar

14. McManus DD, Piacentine SM, Lessard D, et al. Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol. 2011;108:477-482. doi: 10.1016/j.amjcard.2011.03.074.10.1016/j.amjcard.2011.03.074314974621624538Open DOISearch in Google Scholar

15. Chan CM, Chen WL, Kuo HY, et al. Circadian variation of acute myocardial infarction in young people. Am J Emerg Med. 2012;30:1461-1465. doi: 10.1016/j.ajem.2011.11.019.10.1016/j.ajem.2011.11.01922244223Open DOISearch in Google Scholar

16. Goliasch G, Oravec S, Blessberger H, et al. Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age). Eur J Clin Invest. 2012;42:631-636. doi: 10.1111/j.1365-2362.2011.02629.x.10.1111/j.1365-2362.2011.02629.x22150092Open DOISearch in Google Scholar

17. Hosseini SK, Soleimani A, Karimi AA, et al. Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age. Monaldi Arch Chest Dis. 2009;72:71-76. doi: 10.4081/monaldi.2009.331.10.4081/monaldi.2009.33119947188Open DOISearch in Google Scholar

18. Larsen GK, Seth M, Gurm HS. The ongoing importance of smoking as a powerful risk factor for ST-segment elevation myocardial infarction in young patients. JAMA Intern Med. 2013;173:1261-1262. doi: 10.1001/jamainternmed.2013.6075.10.1001/jamainternmed.2013.607523712862Open DOISearch in Google Scholar

19. Aggarwal A, Aggarwal S, Goel A, Sharma V, Dwivedi S. A retrospective case-control study of modifiable risk factors and cutaneous markers in Indian patients with young coronary artery disease. JRSM Cardiovasc Dis. 2012;1:pii:cvd.2012.012010. doi: 10.1258/cvd.2012.012010.10.1258/cvd.2012.012010373832524175065Open DOISearch in Google Scholar

20. Calais F, Eriksson Ö, Hedberg P, Rosenblad A, Leppert J, Fröbert O. Incremental prognostic value of coronary and systemic atherosclerosis after myocardial infarction. Int J Cardiol. 2018;261:6-11. doi: 10.1016/j.ijcard.2018.02.035.10.1016/j.ijcard.2018.02.03529657058Open DOISearch in Google Scholar

21. Chaudhary P, Agarwal N, Kulshrestha M, Kumar A, Chaudhary S, Gupta S. Assesment of myocardial infarction in young patiens. Int J of Cont Med Research. 2016;3:3467-3470.Search in Google Scholar

22. Gostman I, Lotan C, Mosseri M. Clinical manifestation and outcome of acute myocardial infarction in very young patiens. Isr Med Assoc J. 2003;5:633-636.Search in Google Scholar

23. Leifheit-Limson EC, D'Onofrio G, Daneshvar M, et al. Sex differences in cardiac risk factors, perceived risk, and health care provider discussion of risk and risk modification among young patients with acute myocardial infarction: the VIRGO study. J Am Coll Cardiol. 2015;66:1949-1957. doi: 10.1016/j.jacc.2015.08.859.10.1016/j.jacc.2015.08.859462872726515996Open DOISearch in Google Scholar

24. Lu Y, Zhou S, Dreyer RP, et al. Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: Results from the VIRGO study. Am Heart J. 2017;183:74-84. doi: 10.1016/j.ahj.2016.09.012.10.1016/j.ahj.2016.09.012545939627979045Open DOISearch in Google Scholar

25. Kehera S, Kolte D, Gupta T, et al. Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in young adults in the United States. J Am Coll Cardiol. 2015;66:1961-1972. doi: 10.1016/j.jacc.2015.08.865.10.1016/j.jacc.2015.08.86526515998Open DOISearch in Google Scholar

26. Incalcaterra E, Caruso M, Lo Presti R, Caimi G. Myocardial infarction in young adults: risk factors, clinical characteristics and prognostic according to our experience. ClinTer. 2013;164:77-82. doi: 10.7417/CT.2013.1535.10.7417/CT.2013.153523698218Open DOISearch in Google Scholar

27. Siegerink B, Maino A, Algra A, Rosendaal FR. Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women. J Thromb Haemost. 2015;13:1568-1575. doi: 10.1111/jth.13045.10.1111/jth.1304526178535Open DOISearch in Google Scholar

28. Sreckovic B, Dimitrijevic V, Soldatovic I, et al. Homocysteine is a marker for metabolic syndrome and atherosclerosis. Diabetes Metab Syndr. 2017;11:179-182. doi: 10.1016/j.dsx.2016.08.026.10.1016/j.dsx.2016.08.02627600468Open DOISearch in Google Scholar

29. Patel N, Elsaid O, Shenoy A, Sharma A, McFarlane SI. Obesity paradox in patients undergoing coronary intervention: A review. World J Cardiol. 2017;9:731-736. doi: 10.4330/wjc.v9.i9.73110.4330/wjc.v9.i9.731563353629081905Open DOISearch in Google Scholar

30. Wiesbauer F, Blessberger H, Azar D, et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age). Eur Heart J. 2009;30:1073-1079. doi: 10.1093/eurheartj/ehp051.10.1093/eurheartj/ehp05119276196Open DOISearch in Google Scholar

31. Nazir S, Tachamo N, Lohani S, Hingorani R, Poudel DR, Donato A. Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review. Coron Artery Dis. 2017;28:332-335. doi: 10.1097/MCA.0000000000000476.10.1097/MCA.000000000000047628225386Open DOISearch in Google Scholar

32. Varner CK, Marquardt CW, Pickens PV. Antiphosphatidylserine antibody as a cause of multiple dural venous sinus thromboses and ST-elevation myocardial infarction. Am J Case Rep. 2018;19:1042-1046. doi: 10.12659/AJCR.909698.10.12659/AJCR.909698612818130166503Search in Google Scholar

33. Maino A, Siegerink B, Algra A, Peyvandi F, Rosendaal RF. Recurrence and mortality in young women with myocardial infarction or ischemic stroke-long term follow up of the risk of arterial thrombosis in relation to oral contraceptives (RATIO) Study. JAMA Intern Med. 2016;176:134-136. doi: 10.1001/jamainternmed.2015.6523.10.1001/jamainternmed.2015.652326595612Open DOISearch in Google Scholar

34. Maor E, Fefer P, Varon D, et al. Thrombophilic state in young patients with acute myocardial infarction. J Thromb Thrombolysis. 2015;39:474-480. doi: 10.1007/s11239-014-1166-2.10.1007/s11239-014-1166-2Open DOISearch in Google Scholar

35. Cervera R, Piette JC, Font J, et al. Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-1027.10.1002/art.10187Search in Google Scholar

36. Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cocharne Database Syst Rez. 2015;8:CD011054. doi: 10.1002/14651858.CD011054.pub2.10.1002/14651858.CD011054.pub2Search in Google Scholar

37. Vasilcu TF, Stătescu C, Sascău R, et al. Cardiopulmonary testing and biochemical profile of coronary patients subject to cardiovascular recovery programs. Rev Chim Bucharest. 2018;69:2283-2286.10.37358/RC.18.8.6516Search in Google Scholar

38. Velibey Y, Sahin S, Tanık O, Keskin M, Bolca O, Eren M. Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated. Am J Emerg Med. 2015;33:1114.e1-3. doi: 10.1016/j.ajem.2015.01.032.10.1016/j.ajem.2015.01.032Open DOISearch in Google Scholar

39. Doughty M, Mehta R, Bruckman D, et al. Acute myocardial infarction in the young–The University of Michigan experience. Am Heart J. 2002;143:56-62.10.1067/mhj.2002.120300Search in Google Scholar

40. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol. 1995;26:654-661.10.1016/0735-1097(95)00254-2Search in Google Scholar

41. Tweet MS, Hayes SN, Pitta SR, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012;126:579-588. doi: 10.1161/CIRCULATIONAHA.112.105718.10.1161/CIRCULATIONAHA.112.10571822800851Open DOISearch in Google Scholar

42. Moccetti T, Malacrida R, Pasotti E, et al. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarto Miocardico (GISSI-2). Arch Intern Med. 1997;157:865-869.10.1001/archinte.1997.00440290049005Search in Google Scholar

43. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-97.10.1001/jama.290.1.8612837716Search in Google Scholar

44. Puymirat E, Taldir G, Aissaoui N, et al. Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome). JACC Cardiovasc Interv. 2012;5:893-902. doi: 10.1016/j.jcin.2012.05.008.10.1016/j.jcin.2012.05.00822995875Open DOISearch in Google Scholar

45. Lichtman JH, Leifheit EC, Safdar B, et al. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). Circulation. 2018;137:781-790. doi: 10.1161/CIRCULATIONAHA.117.031650.10.1161/CIRCULATIONAHA.117.031650582274729459463Open DOISearch in Google Scholar

46. Ziegelstein RC. Depression after myocardial infarction. Cardiol Rev. 2001;9:45-51.10.1097/00045415-200101000-0000911174915Search in Google Scholar

47. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosom Med. 1995;57:582-591.10.1097/00006842-199511000-000118600485Search in Google Scholar

48. Longmore RB, Spertus JA, Alexander KP, et al. Angina frequency after myocardial infarction and quality of life in older versus younger adults: the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study. Am Heart J. 2011;161:631-638. doi: 10.1016/j.ahj.2010.12.005.10.1016/j.ahj.2010.12.00521392621Open DOISearch in Google Scholar

eISSN:
2457-5518
Język:
Angielski